Pharmaceutical Statistics

Cover image for Vol. 15 Issue 4

Editors-in-Chief: David Morgan, Thomas Permutt and Gerd Rosenkranz

Impact Factor: 1.235

ISI Journal Citation Reports © Ranking: 2015: 45/123 (Statistics & Probability); 208/253 (Pharmacology & Pharmacy)

Online ISSN: 1539-1612

Most Cited


These are the most cited articles published in Pharmaceutical Statistics in 2014 or 2015. The data has been compiled from Thomson ISI Web of Science®.

Gamalo, Meg A.; Tiwari, Ram C.; LaVange, Lisa M.
Bayesian approach to the design and analysis of non-inferiority trials for anti-infective products
Pharmaceutical Statistics 2014, vol. 13, p. 25

Viele, Kert; Berry, Scott; Neuenschwander, Beat; Amzal, Billy; Chen, Fang; Enas, Nathan; Hobbs, Brian; Ibrahim, Joseph G.; Kinnersley, Nelson; Lindborg, Stacy; Micallef, Sandrine; Roychoudhury, Satrajit; Thompson, Laura
Use of historical control data for assessing treatment effects in clinical trials
Pharmaceutical Statistics 2014, vol. 13, p. 41

Hughes, Sara; Wells, Karen; McSorley, Paul; Freeman, Andrew
Preparing individual patient data from clinical trials for sharing: the GlaxoSmithKline approach
Pharmaceutical Statistics 2014, vol. 13, p. 179

Ohlssen, David; Price, Karen L.; Xia, H. Amy; Hong, Hwanhee; Kerman, Jouni; Fu, Haoda; Quartey, George; Heilmann, Cory R.; Ma, Haijun; Carlin, Bradley P.
Guidance on the implementation and reporting of a drug safety Bayesian network meta-analysis
Pharmaceutical Statistics 2014, vol. 13, p. 55

Cuffe, Robert L.; Lawrence, David; Stone, Andrew; Vandemeulebroecke, Marc
When is a seamless study desirable? Case studies from different pharmaceutical sponsors
Pharmaceutical Statistics 2014, vol. 13, p. 229

Price, Karen L.; Xia, H. Amy; Lakshminarayanan, Mani; Madigan, David; Manner, David; Scott, John; Stamey, James D.; Thompson, Laura
Bayesian methods for design and analysis of safety trials
Pharmaceutical Statistics 2014, vol. 13, p. 13

Golkowski, Daniel; Friede, Tim; Kieser, Meinhard
Blinded sample size re-estimation in crossover bioequivalence trials
Pharmaceutical Statistics 2014, vol. 13, p. 157

Lu, Kaifeng
An extension of the placebo-based pattern-mixture model
Pharmaceutical Statistics 2014, vol. 13, p. 103

Munda, Marco; Legrand, Catherine
Adjusting for centre heterogeneity in multicentre clinical trials with a time-to-event outcome
Pharmaceutical Statistics 2014, vol. 13, p. 145

Kubo, Yumi; Sterling, Lulu Ren; Parfrey, Patrick S.; Gill, Karminder; Mahaffey, Kenneth W.; Gioni, Ioanna; Trotman, Marie-Louise; Dehmel, Bastian; Chertow, Glenn M.
Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial
Pharmaceutical Statistics 2015, vol. 14, p. 242

Ghosh, Palash; Dewanji, Anup
Effect of reporting bias in the analysis of spontaneous reporting data
Pharmaceutical Statistics 2015, vol. 14, p. 20

Kunz, Cornelia Ursula; Friede, Tim; Parsons, Nick; Todd, Susan; Stallard, Nigel
Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome data
Pharmaceutical Statistics 2014, vol. 13, p. 238

Riviere, Marie-Karelle; Yuan, Ying; Dubois, Frederic; Zohar, Sarah
A Bayesian dose-finding design for drug combination clinical trials based on the logistic model
Pharmaceutical Statistics 2014, vol. 13, p. 247

Lu, Tzu-Pin; Chen, James J.
Identification of drug-induced toxicity biomarkers for treatment determination
Pharmaceutical Statistics 2015, vol. 14, p. 284

Alonso, Ariel; Milanzi, Elasma; Molenberghs, Geert; Buyck, Christophe; Bijnens, Luc
Impact of selection bias on the evaluation of clusters of chemical compounds in the drug discovery process
Pharmaceutical Statistics 2015, vol. 14, p. 129

Flight, Laura; Julious, Steven A.
The disagreeable behaviour of the kappa statistic
Pharmaceutical Statistics 2015, vol. 14, p. 74

Brain, P.; Kirby, S.; Larionov, R.
Fitting Emax models to clinical trial dose-response data when the high dose asymptote is ill defined
Pharmaceutical Statistics 2014, vol. 13, p. 364

Bretz, Frank; Westfall, Peter H.
Multiplicity and replicability: two sides of the same coin
Pharmaceutical Statistics 2014, vol. 13, p. 343

Dunning, Andrew J.; Reeves, John
Control of type 1 error in a hybrid complete two-period vaccine efficacy trial
Pharmaceutical Statistics 2014, vol. 13, p. 397

Senn, Stephen
A note regarding meta-analysis of sequential trials with stopping for efficacy
Pharmaceutical Statistics 2014, vol. 13, p. 371

Last update: 12-1-2016

SEARCH

SEARCH BY CITATION